To clarify that the overall trade negotiating objectives of the United States include avoiding provisions in trade agreements that restrict the access of consumers in the United States to pharmaceutical imports, and for other purposes.
The bill’s titles are written by its sponsor.
Jul 28, 2005
109th Congress, 2005–2006
Died in a previous Congress
This bill was introduced on July 28, 2005, in a previous session of Congress, but was not enacted.
Representative for Kentucky's 3rd congressional district
Read Text »
Last Updated: Jul 28, 2005
Length: 4 pages
This is the first step in the legislative process.
H.R. 3583 (109th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 109th Congress, which met from Jan 4, 2005 to Dec 9, 2006. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2016). H.R. 3583 — 109th Congress: Protecting Free Trade in Pharmaceuticals Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr3583
“H.R. 3583 — 109th Congress: Protecting Free Trade in Pharmaceuticals Act of 2005.” www.GovTrack.us. 2005. October 28, 2016 <https://www.govtrack.us/congress/bills/109/hr3583>
|title=H.R. 3583 (109th)
|accessdate=October 28, 2016
|author=109th Congress (2005)
|date=July 28, 2005
|quote=Protecting Free Trade in Pharmaceuticals Act of 2005
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.